NYSE

ADC Therapeutics SA

ADCT

1 story

$189M Market cap · 2026-10-15

ADCT · long

ADC Therapeutics centers on ZYNLONTA, an approved CD19-directed antibody-drug conjugate, after shares rose from roughly $4.

Value Investors Club Jul 20